The pharmaceutical market in China is expected to reach a projected revenue of US$ 126,587.7 million by 2030. A compound annual growth rate of 7.8% is expected of China pharmaceutical market from 2025 to 2030. Biologics & Biosimilars (Large Molecules) is the most lucrative molecule segment registering the fastest growth during the forecast period.

The pharmaceutical market in China is expected to reach a projected revenue of US$ 126,587.7 million by 2030. A compound annual growth rate of 7.8% is expected of China pharmaceutical market from 2025 to 2030. Biologics & Biosimilars (Large Molecules) is the most lucrative molecule segment registering the fastest growth during the forecast period.